NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE161420 Query DataSets for GSE161420
Status Public on Apr 21, 2021
Title Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (bulkRNA-Seq and Exome-Seq)
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome variation profiling by high throughput sequencing
Summary Divergent resistance mechanisms to HER2-targeted therapies in breast cancer
 
Overall design Bulk RNA-Seq and exome seq on DNA and RNA of two HER+ PDX models treated with anti-HER2 drugs
 
Contributor(s) Janiszewska M, Stein S, Michor F, Polyak K
Citation(s) 33886505
Submission date Nov 13, 2020
Last update date Jul 20, 2021
Contact name Kornelia Polyak
E-mail(s) kornelia_polyak@dfci.harvard.edu
Phone 617-632-2106
Organization name Dana-Farber Cancer Institute
Department Medical Oncology
Lab Polyak
Street address 450 Brookline Ave
City Boston
State/province MA
ZIP/Postal code 02215
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (60)
GSM4906780 MJH1_G1M1
GSM4906781 MJH1_G1M2
GSM4906782 MJH1_G1M3
This SubSeries is part of SuperSeries:
GSE161423 Divergent resistance mechanisms to HER2-targeted therapies in breast cancer
Relations
BioProject PRJNA678282
SRA SRP292492

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE161420_HERT1combined-gene-level-counts.tsv.gz 642.5 Kb (ftp)(http) TSV
GSE161420_HERT2combined-gene-level-counts.tsv.gz 618.4 Kb (ftp)(http) TSV
GSE161420_RAW.tar 84.1 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap